Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease (2020)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; GLASER, TALITA - IQ ; GIACOMELLI, ÁGATHA OLIVEIRA - IQ ; RIBEIRO, DEIDIANE ELISA - IQ
- Unidade: IQ
- DOI: 10.1007/s12264-020-00582-8
- Subjects: RECEPTORES; DOENÇA DE PARKINSON; DOENÇAS DOS GÂNGLIOS DE BASE
- Agências de fomento:
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Processo FAPESP: 2019/24553-5 - Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Financiado pela National Key R&D Program of China
- Financiado pela Sichuan Province Science and Technology Support Program
- Financiado pela Russian Science Foundation
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
- Language: Inglês
- Imprenta:
- Source:
- Título: Neuroscience Bulletin
- ISSN: 1673-7067
- Volume/Número/Paginação/Ano: v. 36, n. 11, p. 1299–1314, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
GLASER, Talita et al. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, v. 36, n. 11, p. 1299–1314, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00582-8. Acesso em: 27 dez. 2025. -
APA
Glaser, T., Andrejew, R., Giacomelli, Á. O., Ribeiro, D. E., Marques, L. B., Ye, Q., et al. (2020). Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, 36( 11), 1299–1314. doi:10.1007/s12264-020-00582-8 -
NLM
Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1007/s12264-020-00582-8 -
Vancouver
Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1007/s12264-020-00582-8 - The P2X7 receptor: central hub of brain diseases
- Stem cells: principles and applications
- Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires]
- Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases
- ATP and spontaneous calcium oscillations control neural stem cell fate determination in Huntington’s disease: a novel approach for cell clock research
- Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases
- P2X7 receptor signaling in stress and depression
- Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia
- Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease
- Selection and application of aptamer affinity for protein purification
Informações sobre o DOI: 10.1007/s12264-020-00582-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
